Stockreport

Oricell Therapeutics Announces US$70M Initial Closing of Series C Financing, to Accelerate Global Development of Solid Tumor CAR-T Therapies [Yahoo! Finance]

Talon Capital Corp. - Units  (TLNCU) 
PDF innovative cancer immunotherapy, announced today the closing of a $70M Series C1 financing. The round was co-led by Beijing Medical and Health Care Industry Investment [Read more]